塞马西尼

SU5416 (订货以英文为准)

编号:S125835
CAS号:204005-46-9
分子式:C15H14N2O
分子量:238.28
货号 品牌 包装 目录价 您的价格 库存 数量 购买
S125835-10mg 阿拉丁 10mg ¥139.90
S125835-50mg 阿拉丁 50mg ¥399.90
S125835-1g 阿拉丁 1g ¥2922.90
S125835-250mg 阿拉丁 250mg ¥1081.90
产品名称 SU5416
中文名称 塞马西尼
CAS号 204005-46-9
分子式(M.F.) C15H14N2O
分子量(M.W.) 238.28
储存条件 -20°C储存
熔点221-222 °C
溶解性Soluble in DMSO (5 mg/ml), and ethanol (100 mM). Insoluble in water.
存贮条件储存温度-20°C
应用It was used to study the mechanism of development of cerebral vasculature in zebrafish hindbrain,and study the pulmonary vascular remodeling in response to hypoxia in mouse model of pulmonary arterial hypertension.
产品介绍Semaxanib (SU5416)是VEGFR(Flk-1/KDR)抑制剂,IC50为1.23 μM,比对PDGFRβ的抑制性高20倍,对EGFR,InsR和FGFR无活性。
生化机理VEGFR2 Kinase Inhibitor III is a cell-permeable ATP-competitive inhibitor of Flk-1 (VEGFR2/KDR, kinase insert domain receptor), which is the major growth factor for vascular endothelial cells. This receptor is a type III tyrosine kinase receptor that functions as the main mediator of VEGF-induced endothelial proliferation, survival, and migration. Studies suggest that VEGFR2 Kinase Inhibitor III also inhibits a variety of other receptors such as Met, Flt-3/Flk-2 (FLT-3 receptor tyrosine kinases), Ret, c-Kit, PDGFR, c-Abl and Arg (ABL), and ALK. In addition, VEGFR2 kinase inhibitor III regulates the signaling pathways used by oncogenic RET-transfected cells by regulating the extracellular signal regulated kinase (ERK) and JNK pathways.
别名SU-5416; 1,3-二氢-3-[(3,5-二甲基-1H-吡咯-2-基)亚甲基]-2H-吲哚-2-酮;Semaxinib;SU-5416;VEGFR2 Kinase Inhibitor III; 1,3-Dihydro-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-2H-indol-2-one
搜索质检报告(COA)
搜索MSDS
相关产品
CAS号:9012-76-4
¥ 88.00 C953753-100g
¥ 2750.00 sh246789-100kg
CAS号:40516-57-2
¥ 75.00 C826129-250mg
CAS号:72899-92-4
¥ 117.00 BD01089450-250mg
¥ 128.00 sh7651-500mL
¥ 128.00 sh8754-500mL
¥ 128.00 sh42798-500mL
CAS号:1611-83-2
¥ 180.00 27712B-5g
¥ 128.00 sh54098-500mL